Cabaletta Bio (CABA) Cash & Equivalents (2018 - 2026)
Cabaletta Bio (CABA) recorded Cash & Equivalents of $225.1 million in Q2 2026, up 54.6% from $145.61 million a year earlier.
Powered by 
Analysis
Cabaletta Bio (CABA) Cash & Equivalents (2018 - 2026) Analysis & Trends
At the end of FY2025, Cabaletta Bio reported Cash & Equivalents of $82.98 million, down 49.4% from FY2024.
- Annual Cash & Equivalents has a five-year compound annual growth rate of -3.9% (FY2020 to FY2025).
- Across earlier years, Cash & Equivalents came in at $163.96 million in FY2024 (-15.2%), $193.24 million in FY2023 (+136.8%), $81.61 million in FY2022 (-33.2%) and $122.22 million in FY2021 (+20.5%).
- The Q2 2026 figure is the highest quarterly Cash & Equivalents in data going back to Q4 2018.
- On a year-over-year basis, Cash & Equivalents rose in two of the last seven quarters, with an average decline of 10.0%.
- Peak year-over-year performance for Cash & Equivalents in the last five years was growth of 171.5% in Q2 2023, against a decline of 64.7% in Q3 2025 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 20.42 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 6.57 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 6.85 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 7.62 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 4.89 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 13.99 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 3.18 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 976.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 6.14 Bn |
| 10 | Cabaletta Bio | 325.53 Mn | 325.53 Mn | - | 225.10 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 225.10 Mn |
| Dec 31, 2025 | 82.98 Mn |
| Sep 30, 2025 | 60.21 Mn |
| Jun 30, 2025 | 145.61 Mn |
| Mar 31, 2025 | 131.83 Mn |
| Dec 31, 2024 | 163.96 Mn |
| Sep 30, 2024 | 170.61 Mn |
| Jun 30, 2024 | 178.61 Mn |
| Mar 31, 2024 | 175.29 Mn |
| Dec 31, 2023 | 193.24 Mn |
| Sep 30, 2023 | 115.50 Mn |
| Jun 30, 2023 | 128.07 Mn |
| Mar 31, 2023 | 93.85 Mn |
| Dec 31, 2022 | 81.61 Mn |
| Sep 30, 2022 | 61.16 Mn |
| Jun 30, 2022 | 47.17 Mn |
| Mar 31, 2022 | 59.55 Mn |
| Dec 31, 2021 | 122.22 Mn |
| Sep 30, 2021 | 118.26 Mn |
| Jun 30, 2021 | 99.50 Mn |
API Access
Cabaletta Bio Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=CABA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "CABA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=CABA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();